BICO Group AB (publ) (OTCMKTS:CLLKF – Get Free Report) was the target of a significant decrease in short interest in the month of February. As of February 13th, there was short interest totaling 46 shares, a decrease of 96.5% from the January 29th total of 1,313 shares. Based on an average daily trading volume, of 40 shares, the short-interest ratio is presently 1.2 days. Based on an average daily trading volume, of 40 shares, the short-interest ratio is presently 1.2 days.
BICO Group AB (publ) Price Performance
Shares of OTCMKTS:CLLKF remained flat at C$1.79 during midday trading on Wednesday. BICO Group AB has a 1-year low of C$1.79 and a 1-year high of C$4.21. The business’s 50-day moving average is C$2.07 and its 200 day moving average is C$2.32.
BICO Group AB (publ) Company Profile
BICO Group AB (publ), formerly known as CELLINK AB, is a biotechnology company specializing in the development and commercialization of tools and solutions for life science research. The company’s core offerings include advanced 3D bioprinters, proprietary bioinks, microfluidic devices and cell analytics instruments. These technologies are designed to accelerate drug discovery, tissue engineering and personalized medicine by enabling researchers to create and analyze complex biological models in vitro.
In addition to its flagship bioprinting platforms, BICO provides a broad portfolio of consumables and software that support end-to-end workflows for cell culture and bioprocessing.
Further Reading
- Five stocks we like better than BICO Group AB (publ)
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- This makes me furious
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for BICO Group AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BICO Group AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.
